Teleflex/$TFX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Teleflex
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Ticker
$TFX
Sector
Primary listing
NYSE
Employees
14,100
Headquarters
Website
Teleflex Metrics
BasicAdvanced
$5.8B
31.27
$4.18
1.08
$1.36
1.04%
Price and volume
Market cap
$5.8B
Beta
1.08
52-week high
$235.30
52-week low
$108.90
Average daily volume
517K
Dividend rate
$1.36
Financial strength
Current ratio
2.407
Quick ratio
1.072
Long term debt to equity
45.857
Total debt to equity
47.024
Dividend payout ratio (TTM)
32.17%
Interest coverage (TTM)
8.02%
Profitability
EBITDA (TTM)
914.939
Gross margin (TTM)
55.87%
Net profit margin (TTM)
6.31%
Operating margin (TTM)
21.24%
Effective tax rate (TTM)
22.60%
Revenue per employee (TTM)
$220,000
Management effectiveness
Return on assets (TTM)
5.41%
Return on equity (TTM)
4.36%
Valuation
Price to earnings (TTM)
31.272
Price to revenue (TTM)
1.966
Price to book
1.36
Price to tangible book (TTM)
-9.08
Price to free cash flow (TTM)
15.079
Free cash flow yield (TTM)
6.63%
Free cash flow per share (TTM)
8.66
Dividend yield (TTM)
1.04%
Forward dividend yield
1.04%
Growth
Revenue change (TTM)
1.11%
Earnings per share change (TTM)
-24.95%
3-year revenue growth (CAGR)
2.69%
10-year revenue growth (CAGR)
5.34%
3-year earnings per share growth (CAGR)
-27.04%
10-year earnings per share growth (CAGR)
0.45%
What the Analysts think about Teleflex
Analyst ratings (Buy, Hold, Sell) for Teleflex stock.
Bulls say / Bears say
Teleflex’s revenue in Q2 2025 rose 5.5% year-over-year to $743.3 million, beating analyst estimates of $729.9 million and reflecting strong underlying demand recovery in its device portfolio (Reuters)
The Vascular Access segment posted a 6.0% increase in Q2 revenue to $173.8 million, surpassing consensus estimates of $173.5 million and highlighting continued strength in bloodstream-related medical devices (Reuters)
Teleflex agreed to acquire Palette Life Sciences AB for an upfront $600 million, broadening its interventional urology offerings and positioning the company to capitalize on high-growth urinary and reproductive health markets (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 5 Oct 2025.
Teleflex Financial Performance
Revenues and expenses
Teleflex Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Teleflex stock?
Teleflex (TFX) has a market cap of $5.8B as of October 29, 2025.
What is the P/E ratio for Teleflex stock?
The price to earnings (P/E) ratio for Teleflex (TFX) stock is 31.27 as of October 29, 2025.
Does Teleflex stock pay dividends?
Yes, the Teleflex (TFX) stock pays dividends to shareholders. As of October 29, 2025, the dividend rate is $1.36 and the yield is 1.04%. Teleflex has a payout ratio of 32.17% on a trailing twelve-month basis.
When is the next Teleflex dividend payment date?
The next Teleflex (TFX) dividend payment date is unconfirmed.
What is the beta indicator for Teleflex?
Teleflex (TFX) has a beta rating of 1.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.